等待开盘 10-28 09:30:00 美东时间
0.000
0.00%
SALT LAKE CITY, Oct. 23, 2025 /PRNewswire/ -- Ryan Richards, Chief Financial Officer of Zions Bancorporation (NASDAQ: ZION), will present at the BancAnalysts Association of Boston Conference...
10-24 04:43
Unified architecture connects classrooms, offices, and data centers with centralized control and predictable performanceSALT LAKE CITY, UTAH / ACCESS Newswire / October 23, 2025 / FatPipe, Inc. (NASDAQ:FATN) announced
10-23 21:17
Atlas Salt Inc ( ($TSE:SALT) ) has shared an announcement. Atlas Salt Inc. has ...
10-22 00:08
New device has the potential to help empower decentralized PCR testing in nearly 30,000 primary health centers across India, advancing efforts to improve availability of life-saving TB diagn...
10-16 21:30
Scorpio Tankers Inc. announced it will release its third quarter 2025 earnings on October 30, 2025, followed by a conference call at 9:00 AM EDT/2:00 PM CEST. The call will be available via webcast at www.scorpiotankers.com or the provided link, as well as telephonically. The company currently owns or operates 99 product tankers and provides marine transportation of petroleum products worldwide. Certain forward-looking statements in the release a...
10-16 20:15
SALT LAKE CITY, Oct. 13, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the develop...
10-13 21:30
First Step in Broader Effort to Develop Innovative Financing Tools for the Bitcoin MarketCollaboration Launches Initial Treasury Financing StructureSALT LAKE CITY, UTAH / ACCESS Newswire / October 7, 2025 / KindlyMD,
10-07 20:40
SALT LAKE CITY, Oct. 1, 2025 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy...
10-01 20:05
SALT LAKE CITY, Oct. 1, 2025 /PRNewswire/ -- As Emotional Wellness Month begins, Kevin Guest, executive chairman at USANA Health Sciences (NYSE: USNA), is spotlighting service as one of the ...
10-01 19:38
AbbVie's settlement with generic rivals delays upadacitinib competition in the U.S. until at least 2037, supporting its long-term market presence.
09-11 21:55